[Phospholipase A2 inhibitors].
Tanaka
K
K
Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.
Arita
H
H
Inoue
K
K
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D016718:Arachidonic Acid / Q000378:metabolism; D001419:Bacteria / Q000378:metabolism; D005227:Fatty Acids / Q000737:chemistry / Q000494:pharmacology*; D005658:Fungi / Q000378:metabolism; D006801:Humans; D009285:Naphthoquinones / Q000737:chemistry / Q000494:pharmacology*; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology*; D010456:Peptides, Cyclic; D010741:Phospholipases A / Q000037:antagonists & inhibitors* / Q000145:classification; D054467:Phospholipases A2; D014966:Xanthenes / Q000737:chemistry / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D005227:Fatty Acids; D009285:Naphthoquinones; D009842:Oligopeptides; D010456:Peptides, Cyclic; D014966:Xanthenes; C049901:plipastatin; C072738:thielocin A1beta; D016718:Arachidonic Acid; C045959:plastatin; D010741:Phospholipases A; D054467:Phospholipases A2